Forget This Biotech Stock’s Rally Signals Fresh Jump
NovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
If you ask why you keep overspending, you're not alone. This section breaks down frequent triggers and offers concrete fixes to align spending with goals.
22,309 articlesNovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
A nationwide policy debate over banning institutional single-family rentals risks tightening rental supply and liftin...
Berkshire Hathaway has resumed stock buybacks, purchasing $15 million of its own shares. CEO Greg Abel personally bou...
When a large investor opens million position in an industrial REIT, it signals confidence in long-term cash flow and ...
Bitcoin staged a striking break from a long-standing pattern, defying a rising dollar as ETF inflows surged. Analysts...
A wave of commercial real estate loans is set to mature in 2026, testing lenders’ balance sheets and drawing Bitcoin ...
Celink’s Ryan LaRose outlines how reverse mortgage servicing is shaped by scale pressures and growth limits, driven b...
One year after the pledge, the Strategic Petroleum Reserve remains short of full capacity while crude prices push pas...
U.S. prosecutors seek october 2026 retrial for Tornado Cash co-founder Roman Storm after a hung jury halted the first...
Datarails rolls out FinanceOS, an AI-native platform pitched as a financial operating system designed to disrupt its ...
A major alliance links Polymarket with Palantir and TWG AI to upgrade prediction markets with cutting-edge AI. Learn ...
AI has redefined market leadership, with Nvidia at the center. But a looming $630 billion warning asks investors to s...